🚀$VKTX +28% premarket! VK2735 maintenance data: 22% placebo-adj weight loss at wk33, NO plateau. 97% of weight loss held on biweekly dosing, 90% on MONTHLY. Could be the adherence edge vs LLY
LLY/NVO's obesity duopoly. Strong Buy, PT $92. 💉📉 @VikingTherapeutics #VKTX #Obesity #GLP1
